Literature DB >> 19910013

MHV68 complement regulatory protein facilitates MHV68 replication in primary macrophages in a complement independent manner.

Vera L Tarakanova1, Jerome M Molleston, Megan Goodwin, Herbert W Virgin.   

Abstract

Murine gammaherpesvirus-68 (MHV68) is genetically related to human Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus and provides a tractable model to study gammaherpesvirus-host interactions in vivo and in vitro. The MHV68-encoded v-RCA product inhibits murine complement activation and shares sequence homology with other virus and host regulators of complement activation. Here we show that v-RCA is required for efficient MHV68 replication in primary murine macrophages, but not in murine embryonic fibroblasts. v-RCA-deficient MHV68 mutant viruses display defects in viral DNA synthesis in infected macrophages. Importantly, attenuated growth of v-RCA mutant viruses is not rescued in macrophages lacking critical components of the complement system including C3, indicating that the macrophage-specific role of v-RCA in MHV68 replication is complement-independent. This contrasts with the situation in vivo in which attenuated neurovirulence of v-RCA mutant viruses is rescued in C3-deficient mice. This study shows a novel, complement independent cell-type-specific function of a gammaherpesvirus RCA protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910013      PMCID: PMC2805278          DOI: 10.1016/j.virol.2009.10.030

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  44 in total

1.  RETRACTED: Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans.

Authors:  K H Murthy; S A Smith; V K Ganesh; K W Judge; N Mullin; P N Barlow; C M Ogata; G J Kotwal
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

2.  Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes.

Authors:  Linda F van Dyk; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface.

Authors:  Gaener Rodger; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2002-02       Impact factor: 3.891

4.  A critical role for murine complement regulator crry in fetomaternal tolerance.

Authors:  C Xu; D Mao; V M Holers; B Palanca; A M Cheng; H Molina
Journal:  Science       Date:  2000-01-21       Impact factor: 47.728

5.  Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages.

Authors:  E Flaño; S M Husain; J T Sample; D L Woodland; M A Blackman
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

6.  A mutational analysis of the vaccinia virus B5R protein.

Authors:  Elizabeth C Mathew; Christopher M Sanderson; Ruth Hollinshead; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

7.  Structural requirements for the complement regulatory activities of C4BP.

Authors:  A M Blom; L Kask; B Dahlbäck
Journal:  J Biol Chem       Date:  2001-05-21       Impact factor: 5.157

8.  Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo.

Authors:  David O Willer; Samuel H Speck
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection.

Authors:  Sharookh B Kapadia; Beth Levine; Samuel H Speck; Herbert W Virgin
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

10.  Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes.

Authors:  Sofia Marques; Stacey Efstathiou; K G Smith; Matthias Haury; J Pedro Simas
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  15 in total

1.  Gammaherpesvirus gene expression and DNA synthesis are facilitated by viral protein kinase and histone variant H2AX.

Authors:  Bryan C Mounce; Fei Chin Tsan; Lindsay Droit; Sarah Kohler; Justin M Reitsma; Lisa A Cirillo; Vera L Tarakanova
Journal:  Virology       Date:  2011-09-22       Impact factor: 3.616

2.  Dynamic association of gammaherpesvirus DNA with core histone during de novo lytic infection of primary cells.

Authors:  Bryan C Mounce; Fei Chin Tsan; Sarah Kohler; Lisa A Cirillo; Vera L Tarakanova
Journal:  Virology       Date:  2011-10-20       Impact factor: 3.616

3.  ATM facilitates mouse gammaherpesvirus reactivation from myeloid cells during chronic infection.

Authors:  Joseph M Kulinski; Eric J Darrah; Katarzyna A Broniowska; Wadzanai P Mboko; Bryan C Mounce; Laurent P Malherbe; John A Corbett; Stephen B Gauld; Vera L Tarakanova
Journal:  Virology       Date:  2015-05-21       Impact factor: 3.616

4.  A conserved gammaherpesvirus protein kinase targets histone deacetylases 1 and 2 to facilitate viral replication in primary macrophages.

Authors:  Bryan C Mounce; Wadzanai P Mboko; Tarin M Bigley; Scott S Terhune; Vera L Tarakanova
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

5.  Primary macrophages rely on histone deacetylase 1 and 2 expression to induce type I interferon in response to gammaherpesvirus infection.

Authors:  Bryan C Mounce; Wadzanai P Mboko; Adam J Kanack; Vera L Tarakanova
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

6.  Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection.

Authors:  Joseph M Kulinski; Steven M Leonardo; Bryan C Mounce; Laurent Malherbe; Stephen B Gauld; Vera L Tarakanova
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

7.  Importance of antibody in virus infection and vaccine-mediated protection by a latency-deficient recombinant murine γ-herpesvirus-68.

Authors:  Michael L Freeman; Claire E Burkum; David L Woodland; Ren Sun; Ting-Ting Wu; Marcia A Blackman
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

8.  Interferon regulatory factor 1 restricts gammaherpesvirus replication in primary immune cells.

Authors:  Wadzanai P Mboko; Bryan C Mounce; Joseph Emmer; Eric Darrah; Shailendra B Patel; Vera L Tarakanova
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

9.  Helminth infection reactivates latent γ-herpesvirus via cytokine competition at a viral promoter.

Authors:  T A Reese; B S Wakeman; H S Choi; M M Hufford; S C Huang; X Zhang; M D Buck; A Jezewski; A Kambal; C Y Liu; G Goel; P J Murray; R J Xavier; M H Kaplan; R Renne; S H Speck; M N Artyomov; E J Pearce; H W Virgin
Journal:  Science       Date:  2014-06-26       Impact factor: 47.728

10.  Mouse gammaherpesvirus-68 infection acts as a rheostat to set the level of type I interferon signaling in primary macrophages.

Authors:  Brittani M Wood; Wadzanai P Mboko; Bryan C Mounce; Vera L Tarakanova
Journal:  Virology       Date:  2013-05-23       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.